HealthSellas vaccine extends survival in blood cancer trial, shares surge
Drug developer Sellas Life Sciences said on Tuesday that its experimental vaccine for a type of blood cancer significantly prolonged patients’ lives in a late-stage trial, triggering a record one-day jump in its shares.
Sellas vaccine extends survival in blood cancer trial, shares surge
